Physician profile
Yi Gao
NPI 1457857336
$3,896.86
in general payments reported to CMS, 2019-2025
22 companies · $900 in 2025
The $900 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $265 · 2023: $1,247 · 2024: $1,484 · 2025: $900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,503 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,502.70 |
| Education | $128.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $817.40 | 2022-2025 | Tremfya, Stelara, Simponi |
| Regeneron Healthcare Solutions, INC. | $625.27 | 2022-2025 | Dupixent, Libtayo |
| Abbvie INC. | $575.75 | 2022-2025 | |
| Genzyme Corporation | $508.42 | 2022-2025 | |
| Amgen INC. | $258.74 | 2023-2025 | Otezla, Enbrel, Otezla |
| Pfizer INC. | $211.44 | 2023-2025 | |
| Lilly USA, LLC | $150.52 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Galderma Laboratories, L.P. | $140.86 | 2023-2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $123.84 | 2023-2024 | Zoryve |
| Sun Pharmaceutical Industries INC. | $74.08 | 2024-2025 | |
| Botanix Sb INC | $61.04 | 2025 | Sofdra |
| Ucb, INC. | $56.11 | 2024-2025 | Bimzelx |
| Incyte Corporation | $50.82 | 2022-2023 | Opzelura |
| Leo Pharma INC. | $44.38 | 2024-2025 | Adbry |
| Novartis Pharmaceuticals Corporation | $43.41 | 2022-2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $36.86 | 2024 | Vtama |
| Merck Sharp & Dohme LLC | $28.25 | 2023 | Keytruda |
| E.R. Squibb & Sons, L.L.C. | $21.43 | 2022 | |
| Verrica Pharmaceuticals INC. | $19.05 | 2023 | Ycanth |
| Mayne Pharma Commercial LLC | $16.99 | 2023 | |
| Organon LLC | $16.22 | 2025 | Vtama |
| Krystal Biotech INC | $15.98 | 2025 | Vyjuvek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Gao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.